PALISADE CAPITAL MANAGEMENT, LP - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAC8. A total of 1 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2014$5,283,000
+3.8%
4,000,0000.0%0.13%
-0.8%
Q3 2014$5,091,000
-20.4%
4,000,0000.0%0.13%
-16.8%
Q2 2014$6,398,000
+4.2%
4,000,000
-11.1%
0.16%
+2.6%
Q1 2014$6,143,000
+29.3%
4,500,000
+28.6%
0.15%
+21.8%
Q4 2013$4,751,000
+5.6%
3,500,0000.0%0.12%
+1.6%
Q3 2013$4,501,000
+3.0%
3,500,0000.0%0.12%
-3.2%
Q2 2013$4,371,000
+3.3%
3,500,0000.0%0.13%
-3.8%
Q1 2013$4,232,000
+3.0%
3,500,0000.0%0.13%
-2.2%
Q4 2012$4,110,0003,500,0000.13%
Other shareholders

There were no reported owners of PDL BIOPHARMA INC in Q1 2015.

NameSharesValueWeighting ↓
View complete list of PDL BIOPHARMA INC shareholders